The Nifty 50 constituent- Apollo Hospitals is all set to release its Q2 earnings on November 6 (Wednesday). For the July-September quarter, Zee Business analysts expect consolidated net profit at the healthcare entity to increase by 55 per cent to Rs 361 crore. from Rs 233 crore in the same period of the previous year.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

The enhanced profitablity is anticiapted on the back of improving footfalls and decent numbers from the company's multi-channel digital healthcare platform - Apollo 24/7.

Revenue from operations at the company is seen rising 14 per cent year-on-year (YoY) to Rs 5,524 crore as against Rs 4,847 crore during the same period last year. 

At the operaitonal level, EBITDA or the Earnings Before Interest, Taxes, Depreciation, and Amortization is expected to grow 19 per cent YoY to Rs 748 crore. The same in the year-ago period was at Rs 628 crore. Meanwhile, EBITDA margin is seen to register 60 basis points or 0.6 per cent rise to 13.5 per cent from 12.9 per cent in Q2FY24.

Key monitorable

Investors will eye the company's capacity expansion plans. Additionally, any guidance with respect to occupancy levels in the near future will be largely watched.

Apollo Hospitals Q1 results

During Q1, the company's consolidated net profit rose 83 per cent to Rs 305 crore. Furthermore, revenue from operations during the review period increased 15 per cent on-year to Rs 5,086 crore as against Rs 4,418 crore in the last year's same quarter.

EBITDA growth during the quarter stood at 33 per cent at Rs 675 crore as against Rs 509 crore in the similar period last year.

Apolllo Hospitals share price performance

Ahead of its quarterly performance due on Wednesday, shares of the company traded lower by over 1 per cent at Rs 6,961. In the last one year, the stock has zoomed over 35 per cent.